Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTCRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
STOML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHDC8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPNMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDRD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927815 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WDR93 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL20RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VASH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAI14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDIL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on